Company Monitoring Page for Eisai

latest headlines for company on cafepharma

Eisai launches first startup incubator under its genomics center for dementia
Fierce Biotech
Tue, 07/9/19 - 11:53 am
Tags:
Eisai, incubators, Cambridge, genomics, dementia
Schrödinger hires ex-Eisai, Merck staff for push into clinic
Fierce Biotech
Wed, 06/19/19 - 09:51 am
Tags:
Schrödinger, R&D, Eisai, Merck, biotech
Why Alzheimer's Treatment Hopes Endure Despite High-Profile Drug Failures
Investors Business Daily
Sat, 06/15/19 - 05:44 pm
Tags:
Alzheimer's disease, drug development, Biogen, Eisai
Alzheimer’s R&D projects sidelined as Biogen’s aducanumab shock shakes researchers to the core of their beliefs
Endpoints
Tue, 05/14/19 - 09:56 am
Tags:
Alzheimer's disease, drug development, aducanumab, Biogen, Eisai, BAN2401, Merck, Eli Lilly, AstraZeneca
New Eisai venture arm to focus on digital tech, dementia, cancer
BioCentury
Fri, 05/10/19 - 06:02 pm
Tags:
Eisai, venture capital, dementia, digital technology, cancer
Eisai Continues Alzheimer's Research, Adds 2 Alzheimer's Pros as Execs
BioSpace
Sun, 05/5/19 - 10:36 am
Tags:
Eisai, Biogen, Alzheimer's disease, R&D, aducanumab, BAN2401
After A Big Failure, Scientists And Patients Hunt For A New Type Of Alzheimer's Drug
NPR
Sat, 05/4/19 - 02:35 pm
Tags:
Alzheimer's disease, R&D, drug development, beta amyloid, Biogen, Eisai, aducanumab
Eisai buys Purdue stake in insomnia drug as PDUFA date nears
Fierce Biotech
Wed, 05/1/19 - 10:46 am
Tags:
Eisai, Purdue Pharma, insomnia, lemborexant, FDA
Is a severely damaged Biogen looking to shed its ties to a controversial development partner?
Endpoints
Sat, 03/23/19 - 12:07 pm
Tags:
Biogen, Eisai, Alzheimer's disease, BAN2401
RIP amyloid beta theory? Nope. Biogen partner launches a new PhIII before aducanumab's corpse turned cold
Endpoints
Fri, 03/22/19 - 11:58 am
Tags:
Biogen, Eisai, BAN2401, Alzheimer's disease, clinical trials
Biogen halts Alzheimer's drug trials in 'transformative' failure for the biotech
BioPharma Dive
Thu, 03/21/19 - 09:56 am
Tags:
Biogen, Eisai, Alzheimer's disease, clinical trials, aducanumab
Eisai, Takeda and GARDP hunt for new antibiotics
Pharmaforum
Wed, 12/12/18 - 09:54 am
Tags:
Eisai, Takeda, GARDP, antibiotics, R&D
Eisai, UCL to launch phase I trials of E2814 for Alzheimer’s disease
Pharmaceutical Business Review
Mon, 12/10/18 - 09:47 am
Tags:
Eisai, Alzheimer's disease, E2814, clinical trials, University College London
Careful, reps: Doctors are watching, FDA promo police's latest rebuke shows
Fierce Pharma
Tue, 10/30/18 - 12:15 pm
Tags:
FDA, drug reps, physicians, Eisai, Fycompa, drug marketing
Biogen’s ‘positive’ Alzheimer’s trial has a problem with small numbers
Stat
Thu, 10/25/18 - 11:31 am
Tags:
Biogen, Eisai, BAN2401, Alzheimer's disease
Sleep Well, Wake Up Alert: Eisai and Purdue's Lemborexant Positive in Phase III Trial for Insomnia
BioSpace
Wed, 10/17/18 - 10:23 am
Tags:
Eisai, Purdue Pharma, lemborexant, insomnia
Bial and Eisai confirm effectiveness of epilepsy monotherapy Zebinix
Pharmaceutical Business Review
Tue, 10/9/18 - 09:49 am
Tags:
Bial, Eisai, Zebinix, epilepsy, focal-onset epilepsy
Eisai and Merck Announce China Approval of Lenvima for Treatment of Unresectable Hepatocellular Carcinoma
CP Wire
Wed, 09/5/18 - 10:15 am
Tags:
China, Eisai, Merck, Lenvima, liver cancer, HCC
Wed, 09/5/18 - 09:24 am
Tags:
Eisai, Merck, Lenvima, liver cancer, hepatocellular carcinoma
Biogen and Eisai Report Phase Ib Extension Data for Alzheimer’s Trial
BioSpace
Tue, 08/28/18 - 07:54 pm
Tags:
Biogen, Eisai, aducanumab, clinical trials, Alzheimer's disease

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.